ANHEDONIA
Clinical trials for ANHEDONIA explained in plain language.
Never miss a new study
Get alerted when new ANHEDONIA trials appear
Sign up with your email to follow new studies for ANHEDONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for the joyless: experimental pill targets core symptom of depression
Disease control CompletedThis study tested whether adding a new daily pill called aticaprant to a person's current antidepressant could better treat major depression, specifically for people who experience a severe lack of pleasure (anhedonia). Over 500 adults who weren't getting enough benefit from thei…
Matched conditions: ANHEDONIA
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists test custom brain zaps for stubborn depression
Disease control CompletedThis study tested whether customizing a magnetic brain stimulation treatment could help people with hard-to-treat depression who struggle to feel pleasure. 60 participants received either personalized stimulation, standard stimulation, or a sham (placebo) treatment over one week.…
Matched conditions: ANHEDONIA
Phase: NA • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Brain training tested as new hope for Hard-to-Treat depression
Disease control CompletedThis study tested a personalized brain-training therapy for people with major depression who struggle to feel pleasure. 19 participants were randomly assigned to receive either the real therapy or a sham version to compare safety and effectiveness. The goal was to see if this the…
Matched conditions: ANHEDONIA
Phase: NA • Sponsor: GrayMatters Health Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for the joyless: pill aims to restore pleasure in Tough-to-Treat depression
Disease control CompletedThis study tested whether adding a new drug called aticaprant to a person's current antidepressant could help improve symptoms in adults with major depression who also experience a severe loss of pleasure (anhedonia) and haven't gotten enough relief from their current medication.…
Matched conditions: ANHEDONIA
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 02, 2026 15:21 UTC
-
Can a family program shield kids from inheriting depression?
Prevention CompletedThis study tested a family-focused program designed to prevent depression in children whose mothers have a history of depression. It involved 73 children aged 8-12 and their mothers, who participated in 8 online sessions. The main goal was to see if the program could improve how …
Matched conditions: ANHEDONIA
Phase: NA • Sponsor: Vanderbilt University • Aim: Prevention
Last updated Mar 31, 2026 12:12 UTC
-
Parkinson's drug tested as potential boost for 'Emotional Numbness' in depression
Symptom relief CompletedThis small, early-stage study tested whether adding the drug pramipexole could help people with depression who specifically struggle with anhedonia—the inability to feel pleasure or motivation. The drug, typically used for Parkinson's disease, was given alongside participants' ex…
Matched conditions: ANHEDONIA
Phase: PHASE2 • Sponsor: Region Skane • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
New depression drug shows promise in early testing
Symptom relief CompletedThis study tested a new drug called ALTO-203 for people with major depression, especially those who struggle with a lack of pleasure (anhedonia). It involved 69 participants who received either the drug or a placebo to see how it affected their mood and alertness, and to check it…
Matched conditions: ANHEDONIA
Phase: PHASE2 • Sponsor: Alto Neuroscience • Aim: Symptom relief
Last updated Mar 09, 2026 14:22 UTC
-
Scientists probe Brain's reward system during inflammation in aging
Knowledge-focused CompletedThis study aimed to understand how inflammation might affect feelings of pleasure and motivation in older adults, particularly those with anxiety. Researchers gave 40 participants aged 60-80 either a substance that causes temporary inflammation or a placebo, then measured their m…
Matched conditions: ANHEDONIA
Phase: PHASE1 • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Scientists probe link between Body's inflammation and depression in women
Knowledge-focused CompletedThis study aimed to understand how temporary inflammation might affect the brain's reward system—how we anticipate and enjoy things—in women. Researchers gave 40 healthy, premenopausal women either a low-dose substance to trigger a brief inflammatory response or a placebo, then m…
Matched conditions: ANHEDONIA
Phase: PHASE1 • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC